Foghorn Therapeutics Inc.
NASDAQ:FHTX

Watchlist Manager
Foghorn Therapeutics Inc. Logo
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Watchlist
Price: 4.87 USD 3.4%
Market Cap: 271.5m USD

Intrinsic Value

The intrinsic value of one FHTX stock under the Base Case scenario is 4.95 USD. Compared to the current market price of 4.87 USD, Foghorn Therapeutics Inc. is Undervalued by 2%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

FHTX Intrinsic Value
4.95 USD
Undervaluation 2%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Foghorn Therapeutics Inc.

What is Valuation History?
Compare FHTX to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about FHTX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Foghorn Therapeutics Inc.
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Foghorn Therapeutics Inc.

Current Assets 203.8m
Cash & Short-Term Investments 198.7m
Other Current Assets 5.2m
Non-Current Assets 22.4m
PP&E 20.4m
Other Non-Current Assets 2m
Efficiency

Free Cash Flow Analysis
Foghorn Therapeutics Inc.

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Foghorn Therapeutics Inc.

Revenue
24.2m USD
Operating Expenses
-116m USD
Operating Income
-91.9m USD
Other Expenses
16.5m USD
Net Income
-75.4m USD
Fundamental Scores

FHTX Profitability Score
Profitability Due Diligence

Foghorn Therapeutics Inc.'s profitability score is 38/100. The higher the profitability score, the more profitable the company is.

38/100
Profitability
Score

Foghorn Therapeutics Inc.'s profitability score is 38/100. The higher the profitability score, the more profitable the company is.

FHTX Solvency Score
Solvency Due Diligence

Foghorn Therapeutics Inc.'s solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
49/100
Solvency
Score

Foghorn Therapeutics Inc.'s solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FHTX Price Targets Summary
Foghorn Therapeutics Inc.

Wall Street analysts forecast FHTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FHTX is 11.9 USD with a low forecast of 9.09 USD and a high forecast of 14.7 USD.

Lowest
Price Target
9.09 USD
87% Upside
Average
Price Target
11.9 USD
144% Upside
Highest
Price Target
14.7 USD
202% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Foghorn Therapeutics Inc.
does not pay dividends
Shareholder Yield

Current shareholder yield for FHTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

FHTX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one FHTX stock?

The intrinsic value of one FHTX stock under the Base Case scenario is 4.95 USD.

Is FHTX stock undervalued or overvalued?

Compared to the current market price of 4.87 USD, Foghorn Therapeutics Inc. is Undervalued by 2%.

Back to Top